SCHEMBL17425935

SCHEMBL17425935

OCCn1cc(-c2cnc3c(n2)N(Cc2ccn4ncnc4c2)NN3)cn1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MET P08581 16/20 0.48
PDE3B Q13370 2/20 0.40
PDE3A Q14432 2/20 0.40
CYP2C9 P11712 1/20 0.40
PDE10A Q9Y233 1/20 0.40
KIT P10721 1/20 0.38
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
MAP4K4 O95819 1/20 0.35
FGFR1 P11362 2/20 0.34
FGFR2 P21802 2/20 0.34
FGFR4 P22455 2/20 0.34
FGFR3 P22607 2/20 0.34
KDR P35968 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24591133 0.87 MET (0.47) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL23128042 0.85 MET (0.47) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL16882542 0.84 MET (0.46) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL24591016 0.81 MET (0.47) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL22475682 0.80 MET (0.42) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL12487863 0.79 MET (0.77) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL19261423 0.79 MET (0.65) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL16882509 0.78 MET (0.45) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL21167685 0.77 MET (0.48) METPDE3BPDE3ACYP2C9PDE10A
SCHEMBL16882492 0.76 MET (0.53) METPDE3BPDE3ACYP2C9PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2966075-A1 CERTAIN TRIAZOLOPYRIDINES, COMPOSITIONS THEREOF AND THEIR USE IN THE TREATMENT OF CANCER. Hutchison Medipharma Limited (CN) 2016-01-13 EP disclosed